Page last updated: 2024-10-21

tacrine and Basal Ganglia Diseases

tacrine has been researched along with Basal Ganglia Diseases in 3 studies

Tacrine: A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders.
tacrine : A member of the class of acridines that is 1,2,3,4-tetrahydroacridine substituted by an amino group at position 9. It is used in the treatment of Alzheimer's disease.

Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.

Research Excerpts

ExcerptRelevanceReference

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Simard, M1
van Reekum, R1
Trevitt, J1
Atherton, A1
Aberman, J1
Salamone, JD1
Riekkinen, P2
Sirviö, J1
Riekkinen, M1

Reviews

1 review available for tacrine and Basal Ganglia Diseases

ArticleYear
The acetylcholinesterase inhibitors for treatment of cognitive and behavioral symptoms in dementia with Lewy bodies.
    The Journal of neuropsychiatry and clinical neurosciences, 2004,Fall, Volume: 16, Issue:4

    Topics: Aged; Basal Ganglia Diseases; Behavior; Cholinesterase Inhibitors; Clinical Trials as Topic; Cogniti

2004

Other Studies

2 other studies available for tacrine and Basal Ganglia Diseases

ArticleYear
Effects of subchronic administration of clozapine, thioridazine and haloperidol on tests related to extrapyramidal motor function in the rat.
    Psychopharmacology, 1998, Volume: 137, Issue:1

    Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Clozapine; Conditioning, Operant; Haloperidol

1998
EEG changes induced by acute and chronic quisqualic or ibotenic acid nucleus basalis lesions are stabilized by tacridine.
    Brain research, 1991, Sep-20, Volume: 559, Issue:2

    Topics: Animals; Basal Ganglia; Basal Ganglia Diseases; Choline O-Acetyltransferase; Electroencephalography;

1991